Idiopathic cytopenia of undetermined significance (ICUS)
Showing 1 - 25 of 5,194
Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles
Not yet recruiting
- Clonal Cytopenia of Undetermined Significance
- +4 more
- Biospecimen Collection
- +6 more
-
Los Angeles, California
- +1 more
Oct 4, 2023
Clonal Cytopenia of Undetermined Significance, CCUS Clonal Cytopenia of Undetermined Significance Trial in United States
Recruiting
- Clonal Cytopenia of Undetermined Significance
- CCUS Clonal Cytopenia of Undetermined Significance
-
Rochester, Minnesota
- +11 more
Jan 24, 2023
Clonal Cytopenia of Undetermined Significance, MDS Trial in Saint Louis (Atorvastatin, Rosuvastatin)
Not yet recruiting
- Clonal Cytopenia of Undetermined Significance
- Myelodysplastic Syndromes
-
Saint Louis, MissouriWashington University School of Medicine
Jul 28, 2022
Clonal Cytopenia of Undetermined Significance Trial in United States (Ivosidenib)
Recruiting
- Clonal Cytopenia of Undetermined Significance
-
Rochester, Minnesota
- +5 more
Apr 4, 2022
CHIP/CCUS Natural History Protocol
Recruiting
- Clonal Hematopoiesis of Indeterminate Potential
- Clonal Cytopenia of Undetermined Significance
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 20, 2022
Clonal Cytopenia of Undetermined Significance Trial in Columbus (procedure, drug, other)
Recruiting
- Clonal Cytopenia of Undetermined Significance
- Biospecimen Collection
- +6 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 12, 2022
Follow-up Study of ICUS and CCUS Patients
Enrolling by invitation
- Myelodysplastic Syndromes
- Observation and necessary supportive care
-
Suzhou, Jiangsu, ChinaThe First Affliated Hospital of Soochow University
Mar 16, 2022
Clonal Cytopenia of Undetermined Significance, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent
Recruiting
- Clonal Cytopenia of Undetermined Significance
- +6 more
- Ascorbic Acid
- +12 more
-
Scottsdale, Arizona
- +4 more
May 26, 2022
The National Myelodysplastic Syndromes (MDS) Study
Recruiting
- Myelodysplastic Syndromes (MDS)
- Therapeutic
-
Anaheim, California
- +280 more
Apr 8, 2022
Idiopathic Chronic Thrombocytopenia of Undetermined Significance
Recruiting
- Thrombocytopenia
- +2 more
- blood sample
- Bone marrow sample
-
Paris, France
- +3 more
Oct 9, 2020
Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms
Not yet recruiting
- Pyruvate Kinase Deficiency
- +10 more
- Blood Draw
-
Boston, MassachusettsMassachusetts General Hospital
May 21, 2021
Molecular Defects in Idiopathic Cytopenia of Undetermined
Unknown status
- Myelodysplastic Syndromes
- ICUS
-
Amiens, FranceCHU Amiens
Aug 2, 2018
Preleukemia, MDS, Cytopenia Trial in Copenhagen (Metformin)
Recruiting
- Preleukemia
- +2 more
-
Copenhagen, Copenhagen N, DenmarkRigshospitalet
Jan 20, 2022
Strategies in Elderly Patients With Advanced Solid Malignancies
Completed
- Colorectum Advanced Malignancies
- +2 more
- venapunction
- bone marrow punction
-
Amsterdam, NetherlandsVU Medical Center
Nov 18, 2020
MDS, Chronic Myelomonocytic Leukemia-1, Cytopenia Trial in Denmark, United States (Vitamin C (ascorbic acid), Placebo)
Recruiting
- Myelodysplastic Syndromes
- +2 more
- Vitamin C (ascorbic acid)
- Placebo
-
Los Angeles, California
- +4 more
Sep 27, 2021
Standardized Flow Cytometric Assay of Peripheral Blood
Active, not recruiting
- Myelodysplastic Syndromes
- Diagnostic Test: Flow cytometry analysis of neutrophil myeloperoxidase expression
-
Grenoble, FranceChu Grenoble Alpes
Oct 29, 2021
Project in First-degree Relatives of Myeloma Patient - The
Recruiting
- Multiple Myeloma
- Monoclonal Gammopathy of Undetermined Significance
- Sample of Blood
-
Shanghai, Shanghai, ChinaZhongshan Hospital,Fudan University
Jul 31, 2023
HPV Infection, HPV-Related Cervical Carcinoma Trial (FluBHPVE6E7, Placebo)
Not yet recruiting
- HPV Infection
- HPV-Related Cervical Carcinoma
- FluBHPVE6E7
- Placebo
- (no location specified)
Apr 24, 2023
Non-Hodgkin Lymphoma, Multiple Myeloma Trial in New York ([68Ga]-Pentixafor)
Recruiting
- Non-Hodgkin Lymphoma
- Multiple Myeloma
-
New York, New YorkMemorial Sloan Kettering Cancer Center
May 4, 2022
Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in United States (Metformin XR, Placebo)
Recruiting
- Monoclonal Gammopathy of Undetermined Significance
- Smoldering Multiple Myeloma
- Metformin XR
- Placebo
-
Boston, Massachusetts
- +6 more
Oct 3, 2022
Connect® Myeloid Disease Registry
Recruiting
- Primary Myelofibrosis
- +2 more
-
Huntsville, Alabama
- +228 more
Mar 30, 2021
Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance Trial in United States (Whole Foods Plant-based Diet, Algae
Recruiting
- Multiple Myeloma
- Monoclonal Gammopathy of Undetermined Significance
- Whole Foods Plant-based Diet
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Jan 3, 2023
Hematological Malignancies - SANGUINE
Recruiting
- Hematologic Malignancy
- Blood sampling for HemaChip screening/diagnostic testing
- Bone marrow sampling
-
Olomouc, Czechia
- +3 more
Feb 9, 2023
Ruling Out Myelodysplastic Syndromes: Protocol forDiagnostic
Recruiting
- Myelodysplastic Syndromes
- Flow cytometric analysis of neutrophil myeloperoxidase expression
-
Clermont-Ferrand, France
- +5 more
Mar 24, 2022